Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Rad Pro Sweden AB
AB
Active
Org 5592994916
Honnörsgatan 10 Apt1102
Engineering activities and related technical consultancy · NACE 7112
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 623K
-41% vs 2023
EBITDA margin
59.1%
+305% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
SEK 328K
+282% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 623K
-41%
EBITDA
SEK 368K
+305%
Net profit
SEK 328K
+282%
Total assets
SEK 422K
+213%
Equity
SEK 354K
+1281%
Employees
1
—
Company information
Legal name
Pharma Rad Pro Sweden AB
Org number
5592994916
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
1 februari 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Levererar professionella och konsulting tjänster inom läkemedel, radiofarmaci och radiofysiska industri.
Contact
Address
Honnörsgatan 10 Apt1102
Email
prab.takhar@pharmaradpro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Linköping
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
482
632
1 063
623
Staff expenses
—
−349
−1 062
−113
EBITDA
287
142
−180
368
Depreciation & amort.
−0
—
—
—
EBIT
287
142
−180
368
Net financials
—
−0
−1
0
Profit before tax
287
142
−181
369
Tax
−59
−30
—
−40
Net profit
228
112
−181
328
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
303
323
135
422
Equity
253
178
26
354
Long-term debt
0
—
0
32
Short-term debt
49
145
109
36
Total debt
49
145
109
68
Financial ratios
5-year trend
EBITDA margin
59.1%
This company
15.8%
Market median
+274% vs market
2021
2024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
2021
2024
Return on equity
92.8%
This company
18.4%
Market median
+404% vs market
2021
2024
Net profit margin
52.7%
This company
8.1%
Market median
+551% vs market
2021
2024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
2021
2024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
FE
Frida Elsa Viola Svensson
Deputy Board Member
2022
PS
Parabjit Singh Takhar
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharma Rad Pro Sweden AB also hold positions in
0
other companies.
Person
Role here
Other companies
Frida Elsa Viola Svensson
Deputy Board Member
0 companies
Parabjit Singh Takhar
Board of Directors
0 companies